These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28965869)

  • 1. Carbon nanomaterials in oncology: an expanding horizon.
    Mehra NK; Jain AK; Nahar M
    Drug Discov Today; 2018 May; 23(5):1016-1025. PubMed ID: 28965869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery.
    Chen D; Dougherty CA; Zhu K; Hong H
    J Control Release; 2015 Jul; 210():230-45. PubMed ID: 25910580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Carbon Nanomaterials for Cancer Phototherapy.
    Jiang BP; Zhou B; Lin Z; Liang H; Shen XC
    Chemistry; 2019 Mar; 25(16):3993-4004. PubMed ID: 30328167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon nanomaterials as versatile platforms for theranostic applications.
    Kim M; Jang J; Cha C
    Drug Discov Today; 2017 Sep; 22(9):1430-1437. PubMed ID: 28533188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and toxicity of nanomaterials for ocular drug delivery applications.
    Mehra NK; Cai D; Kuo L; Hein T; Palakurthi S
    Nanotoxicology; 2016 Sep; 10(7):836-60. PubMed ID: 27027670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon dots: Applications in bioimaging and theranostics.
    Boakye-Yiadom KO; Kesse S; Opoku-Damoah Y; Filli MS; Aquib M; Joelle MMB; Farooq MA; Mavlyanova R; Raza F; Bavi R; Wang B
    Int J Pharm; 2019 Jun; 564():308-317. PubMed ID: 31015004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDITORIAL: Medicinal Chemistry of Nanomaterials for Cancer Theranostics.
    Liang F; Zhang C
    Curr Top Med Chem; 2017; 17(16):1803-1804. PubMed ID: 28589852
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon Nanomaterials: Emerging Roles in Immuno-Oncology.
    Patrick B; Akhtar T; Kousar R; Huang CC; Li XG
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared light-responsive nanomaterials for cancer theranostics.
    Kim H; Chung K; Lee S; Kim DH; Lee H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):23-45. PubMed ID: 25903643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon nanostructures for orthopedic medical applications.
    Yang L; Zhang L; Webster TJ
    Nanomedicine (Lond); 2011 Sep; 6(7):1231-44. PubMed ID: 21929458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in 808 nm Excited Upconversion Nanomaterials as Multifunctional Nanoprobes for Visualized Theranostics in Cancers.
    Zeng L; Wu D; Tian Y; Pan Y; Wu A; Zhang J; Lu G
    Curr Med Chem; 2018; 25(25):2954-2969. PubMed ID: 28322153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
    Chen Y; Wu Y; Sun B; Liu S; Liu H
    Small; 2017 Mar; 13(10):. PubMed ID: 28075057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
    Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
    Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper chalcogenide materials as photothermal agents for cancer treatment.
    Liu K; Liu K; Liu J; Ren Q; Zhao Z; Wu X; Li D; Yuan F; Ye K; Li B
    Nanoscale; 2020 Feb; 12(5):2902-2913. PubMed ID: 31967164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterials for theranostics: recent advances and future challenges.
    Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
    Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
    [No Abstract]   [Full Text] [Related]  

  • 20. External stimulus responsive inorganic nanomaterials for cancer theranostics.
    M SM; Veeranarayanan S; Maekawa T; D SK
    Adv Drug Deliv Rev; 2019 Jan; 138():18-40. PubMed ID: 30321621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.